IDEXX Labs cuts 2024 revenue forecast on lagging vet visits, strong dollar
(Reuters) - IDEXX Laboratories lowered its annual sales forecast after missing quarterly estimates on Wednesday, as the animal diagnostic equipment maker expects a hit from a slowdown in veterinary clinic visits by pet owners and a stronger dollar....
3h ago
J&J advances $6.475 billion settlement of talc cancer lawsuits
By Dietrich Knauth NEW YORK(Reuters) - Johnson & Johnson is moving forward with a $6.475 billion proposed settlement of tens of thousands of lawsuits alleging that its baby powder and other talc products contain asbestos and cause ovarian cancer, t...
4h ago
CVS cuts 2024 profit forecast as insurance unit faces soaring medical costs
(Reuters) -CVS Health Corp slashed its annual profit forecast and missed Wall Street estimates for first-quarter earnings on Wednesday, as elevated demand for non-urgent procedures increased medical costs at its health insurance business. The U.S. heal...
4h ago
Pfizer lifts 2024 profit view on cost cuts, higher COVID vaccine demand
(Reuters) -Pfizer lifted its annual profit forecast on Wednesday, banking on cost cuts and better-than-expected demand for its COVID antiviral treatment and vaccine. The U.S. drugmaker's shares rose nearly 3% before the bell after the company said it e...
4h ago
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
COPENHAGEN (Reuters) - Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing so-called GLP-1 drugs such as Novo Nordisk's Ozempic, the Danish Medicines Agency said on Wednesday. In 2023, 50% of new p...
4h ago
Arizona Senate expected to vote on 1864 abortion ban repeal
By Brad Brooks (Reuters) - The Arizona Senate is expected to vote on Wednesday on a measure to repeal the state's 1864 ban on abortion, which could go into effect within weeks if not struck down. The Arizona House last week passed the measure after...
4h ago
Optomed Oyj, AEYE Health say portable device to detect eye issues gets FDA nod
(Reuters) - A portable device that detects eye conditions that can cause sight loss in people with conditions such as diabetes has received clearance from the U.S. health regulator, its developers Optomed Oyj and AEYE Health said. "I'm thrilled to ...
4h ago
UK's Smith+Nephew retains annual forecasts despite Q1 revenue miss
(Reuters) - British medical equipment maker Smith+Nephew retained its annual revenue and profit forecasts on Wednesday, despite marginally missing market expectations for first-quarter revenue due to a softness in its advanced wound management segm...
7h ago
Haleon's first-quarter revenue misses expectations
(Reuters) - Consumer healthcare company Haleon's first-quarter revenue missed market estimates on Wednesday, due to retailer destocking in the U.S., and a cool down in demand for cold and flu medication after a surge last year. Revenues stood at 2....
8h ago
Novo Nordisk owner to invest $200 million in quantum computing startups
By Martin Coulter LONDON (Reuters) - Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, said on Wednesday it plans to invest around $200 million in quantum computing startups. The company, the investment arm of the...
8h ago
GSK raises full-year profit forecast, says first-half will see stronger sales
(Reuters) -GSK raised its full-year profit forecast on Wednesday and said its sales would be higher in the first six months of the year than the second half on the back of strong demand for its common respiratory virus and shingles vaccines. The London...
8h ago
Stryker lifts 2024 profit forecast on strong demand for medical devices, implants
(Adds media packaging code) (Reuters) - Stryker Corp lifted its full-year profit forecast on Tuesday, owing to resilient demand for the company's medical devices and implants. The joint-implant maker now sees its annual profit per share to be betwe...
13h ago
Neurocrine Biosciences' Huntington's disease drug gets FDA approval
By Sruthi Narasimha Chari (Reuters) -The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences' Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on Tu...
14h ago
Instant view: Biden administration plans to reclassify marijuana
(Reuters) - The U.S. Justice Department on Tuesday moved to make marijuana use a less serious federal crime, taking a step to reclassify the drug out of a category that includes heroin in a shift that, once completed, would shake up cannabis policy...
16h ago
First trial over Zantac cancer claims set to begin in Chicago
By Brendan Pierson (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago. Jury selection began on Tuesday before Judge Daniel Trevino...
16h ago
Almost all US hospitals took financial hit from Change hack, AHA says
By Amina Niasse NEW YORK (Reuters) - Almost all U.S. hospitals were hurt financially by the cyberattack on United Health Group's Change Healthcare unit earlier this year, according to a survey from the American Hospital Association (AHA). The AHA s...
16h ago
Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug
(Reuters) - Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug. U.S.-listed shares of Cronos Group, Tilray Brands and Canopy Growth rose between...
19h ago
Biden administration takes step to make marijuana use a less serious crime
(Reuters) - The U.S. Department of Justice on Tuesday moved to make marijuana use a less serious crime, a source familiar with the matter said. If finalized, the policy change could potentially be the biggest shift in federal cannabis policy in 40 ...
20h ago
Breast cancer screening should begin at age 40, U.S. panel says
By Amina Niasse NEW YORK (Reuters) - Women at average risk for breast cancer should get screening mammograms every other year starting at age 40, the U.S. Preventive Services Task Force (USPSTF) said on Tuesday, cementing insurance coverage for the...
22h ago
Incyte misses quarterly profit on weak sales of lead drug
(Reuters) - Incyte Corp on Tuesday reported first-quarter profit below Wall Street estimates on weak sales of its blood cancer drug Jakafi, sending its shares down 2.4%. The company is working on strengthening its pipeline to counter competition fr...
Apr 30, 2024
GE HealthCare misses quarterly revenue estimates on weakness in China market
(Reuters) - GE HealthCare Technologies missed first-quarter revenue estimates on Tuesday, hurt by lower sales in China market and weaker-than-expected demand for its scanning devices, sending its shares tumbling as much as 12% before the bell. The ...
Apr 30, 2024
Ecolab to sell global surgical unit for $950 million, lifts 2024 profit forecast
(Reuters) - Water solutions company Ecolab said on Tuesday it would sell its global surgical solutions business to private medical supplier Medline for $950 million in cash and raised its full-year profit forecast. The unit made more than $400 mill...
Apr 30, 2024
Walmart to close 51 US health centers
(Reuters) - Walmart said on Tuesday it plans to close 51 health centers across five states in the U.S., as well as shut virtual care centers, as the company looks to optimize its business operations in the country. "This is a difficult decision, an...
Apr 30, 2024
Eli Lilly lifts profit view on diabetes and weight-loss drug strength
(Reuters) -Eli Lilly on Tuesday raised its full-year profit forecast, betting on surging demand for its weight-loss treatment Zepbound and type 2 diabetes drug Mounjaro. Shares of the company rose 3.6% premarket. Sky-rocketing demand for Mounjaro and Z...
Apr 30, 2024
Risk of bird flu spreading to cows outside US, says WHO
GENEVA (Reuters) - A World Health Organization official said on Tuesday there was a risk of H5N1 bird flu virus spreading to cows in other countries beyond the United States through migratory birds. "With the virus carried around the world by migra...
Apr 30, 2024